Literature DB >> 11207222

Brain specific proteins in posthaemorrhagic ventricular dilatation.

A Whitelaw1, L Rosengren, M Blennow.   

Abstract

Median neurofilament and glial fibrillary acidic protein concentrations in the cerebrospinal fluid of 18 infants with posthaemorrhagic ventricular dilatation were 20-200 times higher than control values. S-100 protein in cerebrospinal fluid was four times higher than control values. Glial fibrillary acidic protein concentrations correlated with death or disability and with parenchymal lesions but not with shunt dependence.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11207222      PMCID： PMC1721221          DOI： 10.1136/fn.84.2.f90

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


  5 in total

1.  Glial fibrillary acidic protein is increased in the cerebrospinal fluid of preterm infants with abnormal neurological findings.

Authors:  M Blennow; L Rosengren; S Jonsson; H Forssberg; M Katz-Salamon; H Hagberg; U Hesser; H Lagercrantz
Journal:  Acta Paediatr       Date:  1996-04       Impact factor: 2.299

2.  Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.

Authors:  L E Rosengren; J E Karlsson; J O Karlsson; L I Persson; C Wikkelsø
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

3.  S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.

Authors:  L Persson; H G Hårdemark; J Gustafsson; G Rundström; I Mendel-Hartvig; T Esscher; S Påhlman
Journal:  Stroke       Date:  1987 Sep-Oct       Impact factor: 7.914

4.  Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction.

Authors:  A Aurell; L E Rosengren; B Karlsson; J E Olsson; V Zbornikova; K G Haglid
Journal:  Stroke       Date:  1991-10       Impact factor: 7.914

5.  A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults.

Authors:  L E Rosengren; C Wikkelsø; L Hagberg
Journal:  J Neurosci Methods       Date:  1994-03       Impact factor: 2.390
  5 in total
  9 in total

Review 1.  Perinatal biomarkers in prematurity: early identification of neurologic injury.

Authors:  Maria Andrikopoulou; Ahmad Almalki; Azadeh Farzin; Christina N Cordeiro; Michael V Johnston; Irina Burd
Journal:  Int J Dev Neurosci       Date:  2014-04-24       Impact factor: 2.457

Review 2.  Pathophysiologic mechanisms and strategies for the treatment of post-hemorrhagic hydrocephalus of prematurity.

Authors:  George W Koutsouras; Tatyana Koustov; Stephanie Zyck; Satish Krishnamurthy
Journal:  Childs Nerv Syst       Date:  2022-01-04       Impact factor: 1.475

3.  Perinatal S100B Protein Assessment in Human Unconventional Biological Fluids: A Minireview and New Perspectives.

Authors:  Diego Gazzolo; Fabrizio Michetti
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-16

4.  Mechanisms of hydrocephalus after neonatal and adult intraventricular hemorrhage.

Authors:  Jennifer Strahle; Hugh J L Garton; Cormac O Maher; Karin M Muraszko; Richard F Keep; Guohua Xi
Journal:  Transl Stroke Res       Date:  2012-07       Impact factor: 6.829

Review 5.  Biomarkers in neonatal posthemorrhagic hydrocephalus.

Authors:  Stephanie Merhar
Journal:  Neonatology       Date:  2011-07-27       Impact factor: 4.035

6.  Elevated nerve growth factor and neurotrophin-3 levels in cerebrospinal fluid of children with hydrocephalus.

Authors:  F Hochhaus; P Koehne; C Schäper; O Butenandt; U Felderhoff-Mueser; E Ring-Mrozik; M Obladen; C Bührer
Journal:  BMC Pediatr       Date:  2001-08-24       Impact factor: 2.125

Review 7.  Use of early biomarkers in neonatal brain damage and sepsis: state of the art and future perspectives.

Authors:  Iliana Bersani; Cinzia Auriti; Maria Paola Ronchetti; Giusi Prencipe; Diego Gazzolo; Andrea Dotta
Journal:  Biomed Res Int       Date:  2015-01-18       Impact factor: 3.411

8.  Mesenchymal Stem Cells for Severe Intraventricular Hemorrhage in Preterm Infants: Phase I Dose-Escalation Clinical Trial.

Authors:  So Yoon Ahn; Yun Sil Chang; Se In Sung; Won Soon Park
Journal:  Stem Cells Transl Med       Date:  2018-08-21       Impact factor: 6.940

9.  Biomarkers of brain injury in the premature infant.

Authors:  Martha Douglas-Escobar; Michael D Weiss
Journal:  Front Neurol       Date:  2013-01-22       Impact factor: 4.003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.